IL97814A - Alpha-mannosidase and fucosidase inhibitors their preparation and pharmaceutical compositions containing them - Google Patents

Alpha-mannosidase and fucosidase inhibitors their preparation and pharmaceutical compositions containing them

Info

Publication number
IL97814A
IL97814A IL9781491A IL9781491A IL97814A IL 97814 A IL97814 A IL 97814A IL 9781491 A IL9781491 A IL 9781491A IL 9781491 A IL9781491 A IL 9781491A IL 97814 A IL97814 A IL 97814A
Authority
IL
Israel
Prior art keywords
group
compound
formula
optionally substituted
alkyl
Prior art date
Application number
IL9781491A
Other languages
English (en)
Other versions
IL97814A0 (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IL97814A0 publication Critical patent/IL97814A0/xx
Publication of IL97814A publication Critical patent/IL97814A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
IL9781491A 1990-04-12 1991-04-10 Alpha-mannosidase and fucosidase inhibitors their preparation and pharmaceutical compositions containing them IL97814A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50887590A 1990-04-12 1990-04-12

Publications (2)

Publication Number Publication Date
IL97814A0 IL97814A0 (en) 1992-06-21
IL97814A true IL97814A (en) 1995-08-31

Family

ID=24024437

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9781491A IL97814A (en) 1990-04-12 1991-04-10 Alpha-mannosidase and fucosidase inhibitors their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
EP (1) EP0451834B1 (enExample)
JP (1) JP2955057B2 (enExample)
KR (1) KR100197382B1 (enExample)
CN (1) CN1033638C (enExample)
AT (1) ATE140692T1 (enExample)
AU (1) AU646855B2 (enExample)
CA (1) CA2040058C (enExample)
DE (1) DE69121000T2 (enExample)
DK (1) DK0451834T3 (enExample)
ES (1) ES2092520T3 (enExample)
FI (1) FI109200B (enExample)
GR (1) GR3020934T3 (enExample)
HU (1) HU213396B (enExample)
IE (1) IE75195B1 (enExample)
IL (1) IL97814A (enExample)
NO (1) NO175856C (enExample)
NZ (1) NZ237734A (enExample)
PT (1) PT97339B (enExample)
ZA (1) ZA912588B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773239A (en) * 1993-10-19 1998-06-30 Mount Sinai Hospital Corporation. Mannosidase inhibitors, process for their preparation and their use as therapeutic agents
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
WO1998014446A1 (en) * 1996-10-01 1998-04-09 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
US6395745B1 (en) 1997-04-15 2002-05-28 Glycodesign, Inc. Alkaloid halide salts of swainsonine and methods of use
WO1999021858A1 (en) * 1997-10-24 1999-05-06 Glycodesign Inc. Synthesis of swainsonine salts
KR101784539B1 (ko) * 2010-01-28 2017-10-11 랩터 파마슈티컬스 인코포레이티드 수용체 결합 단백질(ｒａｐ) 펩타이드-푸코시다제 억제제 접합체를 이용한 간 질환의 치료방법
CN101870992A (zh) * 2010-06-21 2010-10-27 天津科技大学 利用基因工程菌耦合发酵合成gdp-岩藻糖的方法
CN102286608B (zh) * 2011-06-08 2014-06-25 郑州安图生物工程股份有限公司 衣原体诊断方法和试剂盒

Also Published As

Publication number Publication date
IE911229A1 (en) 1991-10-23
HU911196D0 (en) 1991-10-28
NZ237734A (en) 1993-05-26
CA2040058A1 (en) 1991-10-13
HUT60994A (en) 1992-11-30
FI109200B (fi) 2002-06-14
AU7416491A (en) 1991-10-17
NO911419D0 (no) 1991-04-11
FI911751L (fi) 1991-10-13
IE75195B1 (en) 1997-08-27
JP2955057B2 (ja) 1999-10-04
DK0451834T3 (da) 1996-08-26
NO911419L (no) 1991-10-14
GR3020934T3 (en) 1996-12-31
ES2092520T3 (es) 1996-12-01
HU213396B (en) 1997-06-30
DE69121000T2 (de) 1996-12-19
DE69121000D1 (de) 1996-08-29
CA2040058C (en) 2001-10-23
JPH04234834A (ja) 1992-08-24
NO175856C (no) 1994-12-21
ZA912588B (en) 1992-01-29
FI911751A0 (fi) 1991-04-11
PT97339B (pt) 1998-08-31
EP0451834A2 (en) 1991-10-16
ATE140692T1 (de) 1996-08-15
CN1055732A (zh) 1991-10-30
NO175856B (enExample) 1994-09-12
PT97339A (pt) 1992-01-31
EP0451834A3 (en) 1993-10-20
EP0451834B1 (en) 1996-07-24
CN1033638C (zh) 1996-12-25
KR100197382B1 (ko) 1999-06-15
IL97814A0 (en) 1992-06-21
AU646855B2 (en) 1994-03-10
KR910018341A (ko) 1991-11-30

Similar Documents

Publication Publication Date Title
EP0687268A1 (en) Spiroazacyclic derivatives as substance p antagonists
CS621585A2 (en) Method of analynprolinone derivatives production
CZ63799A3 (cs) Spirocyklické metalloproteázové inhibitory
US5240707A (en) Alpha-mannosidase and fucosidase inhibitors
CA2040058C (en) Alpha-mannosidase and fucosidase inhibitors
CZ199795A3 (en) Novel pyrrolocarbazoles
EP3953334B1 (en) Novel synthetic options towards the manufacture of (6r,10s)-10- {4-[5-chloro-2-(4-chloro-1h-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6h)- pyrimidinyl}- 1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15 -(metheno)pyrazolo [4,3-b] [1,7] diazacyclotetradecin-5(6h)-one
FI105270B (fi) Menetelmä terapeuttisesti käyttökelpoisten oktahydro-1H-1-pyrindiini-4,5,6,7-terolien valmistamiseksi
AU660641B2 (en) Novel glucohydrolase inhibitors useful as antidiabetic agents
US5952376A (en) Trienyl compounds
KR100501843B1 (ko) 새로운 항암성 비타민 ｄ₃유도체
JPH10503492A (ja) 方 法

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees